Literature DB >> 26232035

Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients.

Cheng Cao1, Jian-Xin Hu1, Yi-Fei Dong2, Rui Zhan1, Ping Li1, Hai Su1, Qiang Peng1, Tao Wu1, Xiao Huang1, Wen-Hua Sun1, Qing-Hua Wu1, Xiao-Shu Cheng1.   

Abstract

BACKGROUND: The association between impaired renal function and increase left ventricular mass was shown to be related to increase in arterial stiffness, which indicates that vascular homeostasis and remodeling may impact the left ventricular hypertrophy (LVH) in patients with renal dysfunction.
METHODS: We measured the peripheral arterial reactive hyperemia index (RHI) and estimated glomerular filtration rate (eGFR) in 317 hypertensive patients comprising 115 normal RHI (RHI > 1.67) and normal eGFR (eGFR ≥ 90ml/min per 1.73 m(2)), 136 low RHI (RHI ≤ 1.67), 27 low eGFR (60 ≤ eGFR < 90ml/min per 1.73 m(2)) and 39 low RHI combined with low eGFR.
RESULTS: Multivariate logistic regression analysis identified lg RHI (odds ratio (OR): 0.001, 95% confidence interval (CI): 10(-6) to 0.426, P = 0.024) and lg eGFR (OR: 0.009, 95% CI: 10(-4) to 0.414, P = 0.016) as independent factors correlated with LVH respectively in hypertensive patients. Compared with normal RHI and eGFR patients, the extent of LVH in patients with either low RHI (OR: 1.224 95% CI: 0.451 to 3.327, P = 0.691) or low eGFR (OR: 0.593 95% CI: 0.070 to 5.037, P = 0.632) did not significantly increase, while it increased significantly in patients with low RHI combined with low eGFR (OR: 4.629 95% CI: 1.592 to 13.458, P = 0.005).
CONCLUSIONS: The concurrence of endothelial and mild renal dysfunction was significantly associated with the severity of LVH in hypertensive patients. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; endothelial dysfunction; hypertension; left ventricular hypertrophy; renal dysfunction.

Mesh:

Year:  2015        PMID: 26232035      PMCID: PMC4886486          DOI: 10.1093/ajh/hpv128

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  36 in total

1.  Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.

Authors:  Giovanni Cerasola; Emilio Nardi; Giuseppe Mulè; Alessandro Palermo; Paola Cusimano; Marco Guarneri; Rosalia Arsena; Gaia Giammarresi; Anna Carola Foraci; Santina Cottone
Journal:  Nephrology (Carlton)       Date:  2010-03       Impact factor: 2.506

2.  Endothelial dysfunction and hypertension.

Authors:  Ralf P Brandes
Journal:  Hypertension       Date:  2014-08-25       Impact factor: 10.190

3.  Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.

Authors:  T Heitzer; T Schlinzig; K Krohn; T Meinertz; T Münzel
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

4.  Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease.

Authors:  Michelle P Kao; Donald S Ang; Stephen J Gandy; M Adnan Nadir; J Graeme Houston; Chim C Lang; Allan D Struthers
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

5.  Endothelial dysfunction predicts regression of hypertensive cardiac mass.

Authors:  Francesco Perticone; Raffaele Maio; Maria Perticone; Sofia Miceli; Angela Sciacqua; Eliezer J Tassone; Ermal Shehaj; Giovanni Tripepi; Giorgio Sesti
Journal:  Int J Cardiol       Date:  2012-04-11       Impact factor: 4.164

Review 6.  Mild renal dysfunction and cardiovascular risk in hypertensive patients.

Authors:  Giovanna Leoncini; Francesca Viazzi; Denise Parodi; Elena Ratto; Simone Vettoretti; Valentina Vaccaro; Maura Ravera; Giacomo Deferrari; Roberto Pontremoli
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

7.  Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.

Authors:  Costas Tsioufis; Elena Vezali; Dimitris Tsiachris; Kyriakos Dimitriadis; Eystathios Taxiarchou; Dimitris Chatzis; Costas Thomopoulos; Dimitris Syrseloudis; Elli Stefanadi; Costas Mihas; Vicky Katsi; Vasilios Papademetriou; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2009-04       Impact factor: 4.844

8.  Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.

Authors:  Jeffrey T Kuvin; Ayan R Patel; Kathleen A Sliney; Natesa G Pandian; Jacob Sheffy; Robert P Schnall; Richard H Karas; James E Udelson
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

9.  FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

Authors:  Neerupma Silswal; Chad D Touchberry; Dorothy R Daniel; Darla L McCarthy; Shiqin Zhang; Jon Andresen; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-07-22       Impact factor: 4.310

10.  [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].

Authors:  José V Lozano; Josep Redón; Luis Cea-Calvo; Cristina Fernández-Pérez; Jorge Navarro; Alvaro Bonet; Jorge González-Esteban
Journal:  Rev Esp Cardiol       Date:  2006-02       Impact factor: 4.753

View more
  5 in total

1.  Independent association between age and circadian systolic blood pressure patterns in adults with hypertension.

Authors:  Ming Deng; Da-Wei Chen; Yi-Fei Dong; Peng Lu; Bi-Ming Zhan; Jian-Qing Xu; Xi-Xin Ji; Ping Li; Xiao-Shu Cheng
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-23       Impact factor: 3.738

2.  Risk of glomerular filtration rate decline in patients with hypertrophic cardiomyopathy and obstructive sleep apnoea.

Authors:  Shao-Yun Wang; Jing Luo; Yi-Fei Dong; Xu-Yang Liu; Ying-Li Fan; Ming Deng; Da-Wei Chen; Ping Li; Xiao-Shu Cheng
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

3.  Interactions Between Body Mass Index and Glomerular Filtration Rate Increase the Identification Ability of Obstructive Sleep Apnea in Patients with Hypertrophic Cardiomyopathy.

Authors:  Rui-Fei Zhou; Ning-Peng Liang; Shuo Chen; Wen-Chao Zhang; Yi-Xi Wang; Yu Wang; Hui-Fang Ji; Yi-Fei Dong
Journal:  Nat Sci Sleep       Date:  2022-09-23

4.  Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts.

Authors:  Hyeon Seok Hwang; Jung Sun Cho; Yu Ah Hong; Yoon Kyung Chang; Suk Young Kim; Seok Joon Shin; Hye Eun Yoon
Journal:  Int J Med Sci       Date:  2018-03-09       Impact factor: 3.738

5.  Aortic Arch Calcification and Cardiomegaly Are Associated with Overall and Cardiovascular Mortality in Hemodialysis Patients.

Authors:  Shih-Hsiang Ou; Yi-Hsueh Liu; Tung-Ling Chung; Jiun-Chi Huang; Pei-Yu Wu; Ho-Ming Su; Szu-Chia Chen
Journal:  J Pers Med       Date:  2021-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.